Is There a Decrease in FDA Regulations?
According to an article in the Economist, FDA’s Commissioner Scott Gottlieb has overseen a fairly significant decrease in the…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2018
Higher Outpatient Drug Spending At 340B Hospitals, According to New…
A new analysis finds that hospitals which participate in the 340B Drug Discount Program have higher per patient outpatient…
House Subcommittee on Health Holds Hearing on MACRA
On March 21, the House Ways and Means Subcommittee on Health held a hearing focused on the implementation of the Medicare Access…
House Finally Passes Right to Try. If First You Don’t Succeed, Try, Try…
The United States Senate previously approved legislation that would allow the terminally ill to access experimental…
FDA Transparency Blueprint Issued
Most everyone even tangentially related to the pharmaceutical industry knows and understands that right now,…
Oregon: Transparency’s Latest Frontier
On March 13, 2018, Oregon Governor Kate Brown signed a bill that requires drugmakers to reportresearch and development and…
Alere Settles False Claims Act Allegations for $33.2 Million
Massachusetts-based medical device manufacturer Alere (acquired by Abbott Laboratories in 2017) and its subsidiary Alere San Diego…
NQF Issues Guidance on Opioid Prescribing Practices
The National Qualify Forum (NQF) recently released new guidelines to support safe and appropriate opioid prescribing to…
Teva and McCaskill: A Game of Cat and Mouse
In Summer 2017, we wrote about Senator Claire McCaskill’s request to Teva Pharmaceutical Industries that they provide…
Preparing for the 2018 Ethical MedTech, APACMed, and China Codes
The Healthcare Convention & Exhibitors Association (HCEA) presented a webinar, “Preparing for the 2018 Ethical…